BOOK
Alzheimer's Disease Decoded: The History, Present, And Future Of Alzheimer's Disease And Dementia
Sahyouni Ronald | Chen Jefferson William | Verma Aradhana
(2016)
Additional Information
Book Details
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Contents | vii | ||
About the Authors | ix | ||
Building a Community | xv | ||
Foreword | xvii | ||
Preface | xix | ||
Quick Reference Guide | xxvii | ||
Part I: Introduction, History, and Overview | 1 | ||
Chapter 1: Introduction to the Brain and Nervous System | 3 | ||
Human Brain: Structure | 5 | ||
The Nervous System | 9 | ||
Human Brain: Building Blocks | 10 | ||
Human Brain: Plasticity | 16 | ||
Human Brain: Development | 17 | ||
Human Brain: Organization | 19 | ||
Human Brain: Memory and Integration | 21 | ||
Studying the Brain | 25 | ||
References | 27 | ||
Chapter 2: Dysfunction | 31 | ||
Normal Age-related Changes | 32 | ||
Smell | 36 | ||
Nervous System Damage and Neurogenesis | 40 | ||
Neurogenesis in Alzheimer’s and Brain Tumors | 41 | ||
References | 45 | ||
Chapter 3: Senility and Normal Aging | 49 | ||
Is Alzheimer’s Disease a Normal Part of Aging? | 49 | ||
Where did the Term “Senility” Come From and Why is it Ubiquitously Associated with Aging?\r | 51 | ||
Cognitive Reserve | 52 | ||
References | 56 | ||
Chapter 4: What is Dementia? | 59 | ||
What Causes Dementia and Alzheimer’s Disease?\r | 64 | ||
References | 70 | ||
Chapter 5: Introduction to Alzheimer’s Disease | 73 | ||
Clinical Symptoms | 76 | ||
Differential Diagnosis | 79 | ||
Pathological findings | 85 | ||
Plaques | 85 | ||
Tangles | 89 | ||
Cerebral Amyloid Angiopathy | 90 | ||
Glial Cell Changes | 90 | ||
Neuronal and Synaptic Loss | 91 | ||
Macroscopic Changes | 92 | ||
Cause of Death | 93 | ||
Natural History | 94 | ||
References | 97 | ||
Chapter 6: Epidemiology of Alzheimer’s Disease | 99 | ||
Gender and Ethnicity | 100 | ||
Brain Size and Function | 101 | ||
Genetics | 101 | ||
Hormones | 101 | ||
Social and Behavioral Effects | 103 | ||
Smoking | 104 | ||
Ethnicity | 105 | ||
Global Effects | 106 | ||
National Effects | 109 | ||
References | 112 | ||
Chapter 7: The History of Alzheimer’s Disease | 121 | ||
The Characterization of the Disease by Dr. Alzheimer in the Early 1900s | 121 | ||
The Development of the Diagnostic Tools | 125 | ||
The Development of Medications | 127 | ||
Clinical Trials Overview | 131 | ||
Solanezumab | 135 | ||
References | 137 | ||
Chapter 8: An Interesting Link | 139 | ||
Human Brain: Evolution | 139 | ||
Three Types of Alzheimer’s Disease | 142 | ||
Trisomy 21 (Down Syndrome) | 145 | ||
The Interesting Role of Sleep in Alzheimer’s Disease | 146 | ||
References | 149 | ||
Part II: Novel Therapies and Future Directions | 153 | ||
Chapter 9: Surgical Treatments for Dementia | 155 | ||
Introduction to Neurosurgery and the “Miraculous” Cures of Dementiain Select Disorders\r | 156 | ||
Surgical Clinical Trials: The Ventriculo- Peritoneal (UP) Shunt Trial\r | 158 | ||
Stem Cell Trials: Pre-clinical Data and Clinical Trials | 159 | ||
Deep-Brain Stimulation | 162 | ||
References | 164 | ||
Chapter 10: Is There a Link to Traumatic Brain Injury? | 165 | ||
Chronic Traumatic Encephalopathy | 168 | ||
TBI in the Military | 169 | ||
References | 170 | ||
Chapter 11: What’s going on Now? | 175 | ||
Vitamin E | 175 | ||
Medications in the Pipeline | 176 | ||
Diagnosis | 179 | ||
Biomarkers and the Alzheimer’s Disease Neuroimaging Initiative Study\r | 184 | ||
Studying the Disease | 186 | ||
References | 188 | ||
Chapter 12: Novel Therapies | 191 | ||
Stem Cells | 191 | ||
Lifestyle Modifications | 193 | ||
Genetic Modification and Personalized Medicine | 202 | ||
Low-Level Light Therapy | 203 | ||
Marijuana (THC) | 207 | ||
THC and Neurogenesis | 209 | ||
THC and Inflammation | 210 | ||
Music Therapy | 211 | ||
References | 215 | ||
Chapter 13: How Can We Solve the Problem? | 221 | ||
Caregiving | 222 | ||
Comprehensive and Integrative Care Clinics | 224 | ||
Risk Stratification | 224 | ||
Risk Reduction and Management | 226 | ||
Early (Correct) Diagnosis | 227 | ||
Prophylactic Treatment | 228 | ||
Diet | 229 | ||
References | 232 | ||
Chapter 14: What Resources Exist? | 235 | ||
Global Resources | 236 | ||
Federal Resources (Lobbying) to Fund Alzheimer’s Research Programs and Scientists | 239 | ||
Organizational and Support Groups for Families | 240 | ||
References | 243 | ||
Acknowledgements | 245 | ||
Note to Readers | 247 | ||
Glossary/Abbreviations | 249 | ||
Index | 255 |